Impact of Diet and/or Exercise-induced Weight Loss on Cardiovascular Risk Factors
Longitudinal Impact of Diet and/or Exercise-induced Weight Loss on Metabolic Markers of Cardiovascular Disease
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this pilot study is to examine the effect of diet and/or exercise-induced weight loss on nontraditional cardiovascular risk factors such as c-reactive protein, insulin levels and sex steroids in obese postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Aug 2003
Longer than P75 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 27, 2007
CompletedFirst Posted
Study publicly available on registry
January 9, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedApril 17, 2020
April 1, 2020
3.5 years
December 27, 2007
April 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
c-reactive protein
baseline, every 1-2 weeks during intervention , then end-of-study
Secondary Outcomes (1)
HOMA (measure of insulin resistance) and sex steroids
baseline, every 1-2 weeks during intervention, then end-of-study
Study Arms (3)
1
ACTIVE COMPARATORDiet alone
2
ACTIVE COMPARATORExercise alone
3
ACTIVE COMPARATORDiet and exercise (combined)
Interventions
Three arms are included: Diet Alone, Exercise Alone, and Combined Diet and Exercise
Eligibility Criteria
You may qualify if:
- obese postmenopausal women
- able to exercise
- non-smokers
You may not qualify if:
- cardiovascular disease
- medications that would interfere with outcome measures (e.g., including ACE inhibitors, lipid lowering medications, beta-blockers, etc)
- known diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale Center for Clinical Investigation
New Haven, Connecticut, 06520, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara I Gulanski, MD, MPH
Yale Univeristy School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 27, 2007
First Posted
January 9, 2008
Study Start
August 1, 2003
Primary Completion
February 1, 2007
Study Completion
December 1, 2008
Last Updated
April 17, 2020
Record last verified: 2020-04